Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma

Oncotarget
Akihiro OhmotoShinichi Yachida

Abstract

Gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC) is a rare and devastating malignancy, and preclinical studies are needed to evaluate potential therapeutic regimens. Here, we examined the antitumor effects of cisplatin (CDDP), etoposide (ETP) and irinotecan (CPT-11) and their combinations on GEP-NEC using three small-cell GEP-NEC cell lines (pancreatic NEC, A99; esophageal NEC, TYUC-1; duodenum NEC, TCC-NECT-2). In vitro studies were conducted using cell viability assays. In vivo experiments were conducted in mice inoculated with A99 or TCC-NECT-2 and treated with no agent, CDDP, CDDP+ETP (EP) or CDDP+CPT-11 (IP). TYUC-1 was the most susceptible to all agents, whereas A99 was refractory. Classical isobolograms showed synergism in both the EP and IP combinations for the three cell lines. In the TCC-NECT-2 mouse model, the IP regimen showed a significant antitumor effect, and CDDP alone showed a marginal effect compared to the control. In contrast, no effect was detected in the A99 model, probably because A99 was established from a metastatic tumor after chemotherapy with EP. Gene expression analysis of the ATP-binding cassette transporters revealed that ATP binding cassette subfamily B member1 (ABCB1) was conspicuously ...Continue Reading

References

Nov 11, 1976·Biochimica Et Biophysica Acta·R L Juliano, V Ling
Jan 11, 2002·The New England Journal of Medicine·Kazumasa NodaUNKNOWN Japan Clinical Oncology Group
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser HannaAlan Sandler
Jul 26, 2006·Digestive Diseases and Sciences·Matthew H KulkeCharles S Fuchs
Aug 29, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Nadja TrillerAndrej Debeljak
Jul 27, 2007·Acta Oncologica·Sung Sook LeeYoon-Koo Kang
Oct 10, 2008·The Cochrane Database of Systematic Reviews·Isuru U AmarasenaKwun Fong
Jul 2, 2009·International Journal of Cancer. Journal International Du Cancer·C LepageUNKNOWN EUROCARE working group
Jun 4, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jingwei JiangQiong Zhan
Feb 18, 2011·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Natsuko Tsuda OkitaKuniaki Shirao
Sep 6, 2011·Oncogene·L GalluzziG Kroemer
Jan 19, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ning ShaoWei Zhu
Jan 26, 2012·JAMA : the Journal of the American Medical Association·Kelly L BoltonUNKNOWN Cancer Genome Atlas Research Network
Jul 24, 2012·Cancer Treatment Reviews·Nicola FazioMonica Giovannini
Sep 13, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H SorbyeU Knigge
Jun 19, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Seiji NihoKanji Nagai
Feb 8, 2014·The American Journal of Surgical Pathology·Olca BasturkDavid S Klimstra
Apr 29, 2014·Cancer·Halfdan SorbyeJames C Yao
May 29, 2015·Nature·Ann-Marie PatchDavid D L Bowtell
Jul 15, 2015·Nature·Julie GeorgeRoman K Thomas
Mar 11, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Natasha RekhtmanMarc Ladanyi
May 16, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T WalterUNKNOWN CEPD investigators

❮ Previous
Next ❯

Citations

Sep 28, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Haishan LinBangwei Cao
May 6, 2019·Annales d'endocrinologie·David Romano

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Assay

Software Mentioned

GraphPad
Prism

Related Concepts

Related Feeds

Carcinoma, Islet Cell

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arises in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Carcinoma here.

Carcinoma, Islet Cell (Keystone)

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arise in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on islet cell carcinoma in this feed.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

© 2022 Meta ULC. All rights reserved